205 related articles for article (PubMed ID: 17029400)
21. Mapping the interfacial binding surface of human secretory group IIa phospholipase A2.
Snitko Y; Koduri RS; Han SK; Othman R; Baker SF; Molini BJ; Wilton DC; Gelb MH; Cho W
Biochemistry; 1997 Nov; 36(47):14325-33. PubMed ID: 9398150
[TBL] [Abstract][Full Text] [Related]
22. Phenylalanine-24 in the N-terminal region of ammodytoxins is important for both enzymic activity and presynaptic toxicity.
Petan T; Krizaj I; Gubensek F; Pungercar J
Biochem J; 2002 Apr; 363(Pt 2):353-8. PubMed ID: 11931665
[TBL] [Abstract][Full Text] [Related]
23. Structural effects of covalent inhibition of phospholipase A2 suggest allosteric coupling between membrane binding and catalytic sites.
Tatulian SA
Biophys J; 2003 Mar; 84(3):1773-83. PubMed ID: 12609879
[TBL] [Abstract][Full Text] [Related]
24. Active site of bee venom phospholipase A2: the role of histidine-34, aspartate-64 and tyrosine-87.
Annand RR; Kontoyianni M; Penzotti JE; Dudler T; Lybrand TP; Gelb MH
Biochemistry; 1996 Apr; 35(14):4591-601. PubMed ID: 8605210
[TBL] [Abstract][Full Text] [Related]
25. Structure, function and interfacial allosterism in phospholipase A2: insight from the anion-assisted dimer.
Bahnson BJ
Arch Biochem Biophys; 2005 Jan; 433(1):96-106. PubMed ID: 15581569
[TBL] [Abstract][Full Text] [Related]
26. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
[TBL] [Abstract][Full Text] [Related]
27. Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis.
Ward RJ; Chioato L; de Oliveira AH; Ruller R; Sá JM
Biochem J; 2002 Feb; 362(Pt 1):89-96. PubMed ID: 11829743
[TBL] [Abstract][Full Text] [Related]
28. Roles of surface hydrophobic residues in the interfacial catalysis of bovine pancreatic phospholipase A2.
Lee BI; Yoon ET; Cho W
Biochemistry; 1996 Apr; 35(13):4231-40. PubMed ID: 8672459
[TBL] [Abstract][Full Text] [Related]
29. Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus.
Koprivnjak T; Peschel A; Gelb MH; Liang NS; Weiss JP
J Biol Chem; 2002 Dec; 277(49):47636-44. PubMed ID: 12359734
[TBL] [Abstract][Full Text] [Related]
30. The molecular basis of phosphatidylcholine preference of human group-V phospholipase A2.
Kim KP; Han SK; Hong M; Cho W
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):643-7. PubMed ID: 10839997
[TBL] [Abstract][Full Text] [Related]
31. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
[TBL] [Abstract][Full Text] [Related]
32. Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation.
Tatulian SA
Biophys J; 2001 Feb; 80(2):789-800. PubMed ID: 11159446
[TBL] [Abstract][Full Text] [Related]
33. The structural and functional essentiality of the N-terminal alpha-helix in the phospholipase A2 of the Taiwan banded krait.
Chang LS; Chang CC; Wu PF
Biochem Mol Biol Int; 1997 May; 41(6):1247-53. PubMed ID: 9161720
[TBL] [Abstract][Full Text] [Related]
34. Interfacial binding of secreted phospholipases A(2): more than electrostatics and a major role for tryptophan.
Gelb MH; Cho W; Wilton DC
Curr Opin Struct Biol; 1999 Aug; 9(4):428-32. PubMed ID: 10449366
[TBL] [Abstract][Full Text] [Related]
35. High specificity of human secretory class II phospholipase A2 for phosphatidic acid.
Snitko Y; Yoon ET; Cho W
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):737-41. PubMed ID: 9032461
[TBL] [Abstract][Full Text] [Related]
36. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
[TBL] [Abstract][Full Text] [Related]
37. Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2.
Han SK; Kim KP; Koduri R; Bittova L; Munoz NM; Leff AR; Wilton DC; Gelb MH; Cho W
J Biol Chem; 1999 Apr; 274(17):11881-8. PubMed ID: 10207008
[TBL] [Abstract][Full Text] [Related]
38. Characterization of suramin binding sites on the human group IIA secreted phospholipase A2 by site-directed mutagenesis and molecular dynamics simulation.
Aragão EA; Vieira DS; Chioato L; Ferreira TL; Lourenzoni MR; Silva SR; Ward RJ
Arch Biochem Biophys; 2012 Mar; 519(1):17-22. PubMed ID: 22248627
[TBL] [Abstract][Full Text] [Related]
39. Conversion of pig pancreas phospholipase A2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein.
Weiss J; Wright G; Bekkers AC; van den Bergh CJ; Verheij HM
J Biol Chem; 1991 Mar; 266(7):4162-7. PubMed ID: 1999411
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of a porcine pancreatic phospholipase A2 mutant. A large conformational change caused by the F63V point mutation.
Thunnissen MM; Franken PA; de Haas GH; Drenth J; Kalk KH; Verheij HM; Dijkstra BW
J Mol Biol; 1993 Aug; 232(3):839-55. PubMed ID: 8355274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
